CWA Asset Management Group LLC purchased a new stake in Core Laboratories Inc. (NYSE:CLB - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 622,453 shares of the oil and gas company's stock, valued at approximately $9,978,000. CWA Asset Management Group LLC owned 1.34% of Core Laboratories at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in the business. Ariel Investments LLC grew its stake in shares of Core Laboratories by 25.5% in the 2nd quarter. Ariel Investments LLC now owns 12,976,463 shares of the oil and gas company's stock valued at $149,489,000 after purchasing an additional 2,634,438 shares during the period. Gendell Jeffrey L raised its holdings in shares of Core Laboratories by 24.6% in the 2nd quarter. Gendell Jeffrey L now owns 569,471 shares of the oil and gas company's stock worth $6,560,000 after buying an additional 112,475 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Core Laboratories by 3.0% during the 2nd quarter. Geode Capital Management LLC now owns 1,114,560 shares of the oil and gas company's stock worth $12,842,000 after buying an additional 32,934 shares during the period. Pacific Ridge Capital Partners LLC acquired a new stake in Core Laboratories in the 3rd quarter valued at $525,000. Finally, Russell Investments Group Ltd. boosted its stake in Core Laboratories by 29.6% in the 2nd quarter. Russell Investments Group Ltd. now owns 196,992 shares of the oil and gas company's stock valued at $2,269,000 after buying an additional 44,949 shares in the last quarter. Institutional investors and hedge funds own 97.81% of the company's stock.
Core Laboratories Stock Performance
Shares of NYSE:CLB opened at $16.18 on Friday. Core Laboratories Inc. has a twelve month low of $9.72 and a twelve month high of $20.36. The firm has a market cap of $753.15 million, a PE ratio of 24.14, a price-to-earnings-growth ratio of 13.93 and a beta of 1.10. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.57 and a current ratio of 2.07. The business has a fifty day moving average of $18.08 and a 200-day moving average of $15.79.
Core Laboratories (NYSE:CLB - Get Free Report) last issued its quarterly earnings results on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.01. Core Laboratories had a net margin of 6.04% and a return on equity of 12.09%. The business had revenue of $138.26 million for the quarter, compared to the consensus estimate of $130.40 million. During the same quarter in the prior year, the company earned $0.22 EPS. The firm's quarterly revenue was up 7.0% on a year-over-year basis. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. On average, equities research analysts predict that Core Laboratories Inc. will post 0.96 EPS for the current fiscal year.
Core Laboratories Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Monday, March 9th. Stockholders of record on Monday, February 16th were paid a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend was Friday, February 13th. Core Laboratories's dividend payout ratio is 5.97%.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reiterated a "hold (c)" rating on shares of Core Laboratories in a research note on Monday, December 29th. Four research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $12.50.
Read Our Latest Research Report on CLB
Core Laboratories Company Profile
(
Free Report)
Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.
The company's portfolio spans two primary service lines: reservoir description and production enhancement.
Further Reading
Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories Inc. (NYSE:CLB - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Core Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Laboratories wasn't on the list.
While Core Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
